Neurologic Outcomes After Extracorporeal Membrane Oxygenation: A Systematic Review

Boyle, Katharine; Felling, Ryan J.; Yiu, Alvin C; Battarjee, Wejdan; Schwartz, Jamie Mc Elrath; Salorio, Cynthia F.; Bembea, Melania M.

doi:10.1097/pcc.0000000000001612

Cited by 79 publications

(65 citation statements)

References 74 publications

(232 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Even though AFM often presents as cardiogenic shock or cardiac arrest, the longterm survival is favourable. 69) Similarly, patients with AFM on ECMO have relatively good survival rates ranging from 58% in neonates to 63%-81% in pediatric patients. 2,30,58,70) The parameters associated with mortality are female gender, arrhythmia during ECMO support, renal failure requiring dialysis, and higher stage of endorgan damage.…”

Section: Discussionmentioning

confidence: 99%

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis

et al. 2021

View full text Add to dashboard Cite

Acute fulminant myocarditis (AFM) occurs as an inflammatory response to an initial myocardial insult. Its rapid and deadly progression calls for prompt diagnosis with aggressive treatment measures. The demonstration of its excellent recovery potential has led to increasing use of mechanical circulatory support, especially extracorporeal membrane oxygenation (ECMO). Arrhythmias, organ failure, elevated cardiac biomarkers, and decreased ventricular function at presentation predict requirement for ECMO. In these patients, ECMO should be considered earlier as the clinical course of AFM can be unpredictable and can lead to rapid haemodynamic collapse. Key uncertainties that clinicians face when managing children with AFM such as timing of initiation of ECMO and left ventricular decompression need further investigation.

show abstract

Section: Discussionmentioning

confidence: 99%

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…They found favorable neurologic outcomes in those without seizures versus those with seizures and noted an increased risk of death associated with electrographic seizures [10]. Seizures during ECMO are associated with neurologic complications such as developmental delay, motor deficits, behavioral problems, and decreased quality of life scores [11,12]. Burst suppression and other severe background abnormalities during ECMO are associated with an increased risk of death.…”

Section: Introductionmentioning

confidence: 99%

EEG is A Predictor of Neuroimaging Abnormalities in Pediatric Extracorporeal Membrane Oxygenation

Fox

Jenks

Farhat

et al. 2020

JCM

View full text Add to dashboard Cite

The goal of this project was to evaluate if severity of electroencephalogram (EEG) during or shortly after being placed on extracorporeal membrane oxygenation (ECMO) would correlate with neuroimaging abnormalities, and if that could be used as an early indicator of neurologic injury. This was a retrospective chart review spanning November 2009 to May 2018. Patients who had an EEG recording during ECMO or within 48 hours after being decannulated (early group) or within 3 months of being on ECMO (late group) were included if they also had ECMO-related neuroimaging. In the early EEG group, severity of the EEG findings of mild, moderate, and severe EEG correlated to mild, moderate, and severe neuroimaging scores. Patients on venoarterial (VA) ECMO were noted to have higher EEG and neuroimaging severity; this was statistically significant. There was no association in the late EEG group to neuroimaging abnormalities. Our study highlights that EEG severity can be an early predictor for neuroimaging abnormalities that can be identified by computed tomography (CT) and or magnetic resonance imaging (MRI). This can provide guidance for both the medical team and families, allowing for a better understanding of overall prognosis.

show abstract

“…Furosemid wurde nach 2 Tagen bei Angabe der Hypakusis sofort abgesetzt, es kam zu keiner Besserung der Hörstörung. Im Zusammenhang mit einer Therapie mittels extrakorporaler Membranoxygenierung (ECMO) wurden selten Hörminderungen beschrieben, jedoch keine Ertaubung [ 11 ].…”

Section: Diskussionunclassified

Ertaubung nach COVID-19?

Gerstacker

Speck

Riemann

et al. 2021

HNO

View full text Add to dashboard Cite

Es wird über den Fall einer akuten Ertaubung beidseits im Rahmen einer Infektion mit dem „severe acute respiratory syndrome coronavirus 2“ (SARS-CoV2) und folgender Coronavirus-19-Erkrankung (COVID-19, „coronavirus disease 2019“) berichtet. Nach Intensivtherapie zur Behandlung eines akuten Lungen- sowie Nierenversagens fiel ein verändertes Hörvermögen auf. Während vor der Infektion subjektive Normakusis beidseits bestand, zeigte sich nun eine Surditas links und an Taubheit grenzende Schwerhörigkeit rechts. Es erfolgte die Cochleaimplantation links und Hörgeräteversorgung rechts. Als Ursache der Hörminderung ist von einer Komplikation durch COVID-19 auszugehen.

show abstract

Neurologic Outcomes After Extracorporeal Membrane Oxygenation: A Systematic Review

Cited by 79 publications

References 74 publications

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis

EEG is A Predictor of Neuroimaging Abnormalities in Pediatric Extracorporeal Membrane Oxygenation

Ertaubung nach COVID-19?

Contact Info

Product

Resources

About